The Button Mushroom: a genuine innovation for Osteoarthritis treatment?
Watch the full replay of the Congres SFR 2024 Roundtable
At the French Society of Rheumatology (SFR) 2024 Congress, KiOmed Pharma hosted a multidisciplinary roundtable featuring experts in rheumatology, orthopedics, rehabilitation, and sports medicine. The discussion focused on the potential of carboxymethyl-chitosan (CMC), a biomaterial derived from the button mushroom, as an innovative option for managing refractory osteoarthritis.
Why the Button Mushroom?
Refractory osteoarthritis, particularly of the knee, presents significant challenges for both practitioners and researchers. Traditional treatments are often limited and do not always meet patients’ needs. Carboxymethyl-chitosan, extracted from the button mushroom, represents an innovative solution: a biomaterial that, in the form of a liquid implant, works as a single injection to relieve persistent osteoarthritis symptoms.
This unique treatment will be presented during the roundtable by renowned experts in the fields of rheumatology, orthopedic surgery, physical rehabilitation, and sports medicine. Their goal? To explore the potential of carboxymethyl-chitosan and discuss its initial applications across diverse settings, from private rheumatology practice to sports medicine.
Roundtable Program
The program, structured around presentations by several experts and moderated by Professor Xavier Chevalier:
- Welcome and Introduction of SpeakersProfessor Xavier Chevalier, Rheumatologist (Créteil)
- Introduction to Osteoarthritis and Focus on Phenotypes of Refractory PatientsOverview of osteoarthritis characteristics, patient phenotypes, and the challenges associated with refractory cases.
Professor Yves Henrotin, Professor of Pathology, Physical Therapy, and Rehabilitation (Liège)
- Review of Carboxymethyl-Chitosan Use in a Sports Center: Insights from a Surgeon and a Physical Medicine SpecialistDiscussion on the applications of carboxymethyl-chitosan in a sports setting, with a focus on preliminary results from an ongoing study at the CUSA center.
Professor Thomas Neri, Orthopedic Surgeon (Saint-Étienne)
Dr. Caroline Perrin, Physical Rehabilitation and Sports Medicine Physician (Saint-Étienne)
- Integration of Carboxymethyl-Chitosan in Sports MedicinePractical insights and experiences with carboxymethyl-chitosan in sports medicine, with real-world examples.
Dr. Claude Marblé, Sports Medicine Physician (Marseille)
- Carboxymethyl-Chitosan in Private Rheumatology PracticeCase-based insights into the use of carboxymethyl-chitosan in private rheumatology practice.
Dr. Henri Lellouche, Rheumatologist (Paris)
Dr. Mohammed Belmouhoub, Rheumatologist (Valence)
- Expert DiscussionExchange between speakers, Q&A, and exploration of future perspectives for the use of carboxymethyl-chitosan in managing patients with refractory osteoarthritis.
Carboxymethyl-Chitosan in Practice: Perspectives and Case Studies
As an innovative implant, carboxymethyl-chitosan stands out for its ability to offer long-term symptom relief for patients with refractory osteoarthritis. During the roundtable, speakers will share their practical experience with this treatment in real-world settings.
For further questions, contact Fabrice Letimier at: fabrice.letimier@kiomedpharma.com
